EP2068622A4 - Method and mixture for in-vivo photochemical cross-linking of collagen - Google Patents

Method and mixture for in-vivo photochemical cross-linking of collagen

Info

Publication number
EP2068622A4
EP2068622A4 EP07810866A EP07810866A EP2068622A4 EP 2068622 A4 EP2068622 A4 EP 2068622A4 EP 07810866 A EP07810866 A EP 07810866A EP 07810866 A EP07810866 A EP 07810866A EP 2068622 A4 EP2068622 A4 EP 2068622A4
Authority
EP
European Patent Office
Prior art keywords
collagen
vivo
linking
mixture
photochemical cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07810866A
Other languages
German (de)
French (fr)
Other versions
EP2068622A2 (en
Inventor
Susanna Grafe
Wolfgang Neuberger
Danilo Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biolitec AG
Original Assignee
Ceramoptec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/880,973 external-priority patent/US20090028926A1/en
Application filed by Ceramoptec GmbH filed Critical Ceramoptec GmbH
Publication of EP2068622A2 publication Critical patent/EP2068622A2/en
Publication of EP2068622A4 publication Critical patent/EP2068622A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP07810866A 2006-07-28 2007-07-27 Method and mixture for in-vivo photochemical cross-linking of collagen Withdrawn EP2068622A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83405906P 2006-07-28 2006-07-28
US11/880,973 US20090028926A1 (en) 2007-07-25 2007-07-25 Method and mixture for in vivo photochemical cross-linking of collagen
PCT/US2007/016952 WO2008013962A2 (en) 2006-07-28 2007-07-27 Method and mixture for in-vivo photochemical cross-linking of collagen

Publications (2)

Publication Number Publication Date
EP2068622A2 EP2068622A2 (en) 2009-06-17
EP2068622A4 true EP2068622A4 (en) 2012-10-10

Family

ID=38982115

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07810866A Withdrawn EP2068622A4 (en) 2006-07-28 2007-07-27 Method and mixture for in-vivo photochemical cross-linking of collagen

Country Status (2)

Country Link
EP (1) EP2068622A4 (en)
WO (1) WO2008013962A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2632187C (en) 2005-11-09 2017-06-27 Klox Technologies Inc. Teeth whitening compositions and methods
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
DK2365829T3 (en) 2008-11-07 2017-07-31 Klox Tech Inc COMBINATION OF AN OXIDANT AND PHOTO ACTIVATOR FOR HEALING OF WOES
JP5794984B2 (en) 2009-07-17 2015-10-14 クロクス テクノロジーズ インコーポレイテッド Combination of oxidizing agents, photosensitizers and wound healing agents for oral disinfection and treatment of oral diseases
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
CN104994830A (en) 2012-09-14 2015-10-21 威朗国际制药公司 Compositions and methods for teeth whitening
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
RU2016103321A (en) 2013-07-03 2017-08-08 Клокс Текнолоджиз Инк. COMPOSITIONS AND METHODS FOR TREATING NON-HEALING RAS
EP3076902A4 (en) 2013-12-03 2017-08-16 Cornell University Method of repairing an annulus and collagen gel composition
WO2015149177A1 (en) 2014-04-01 2015-10-08 Klox Technologies Inc. Tissue filler compositions and methods of use
CA2966010C (en) 2014-10-31 2023-04-11 Klox Technologies Inc. Photoactivatable fibers and fabric media
CN116099049A (en) * 2023-01-20 2023-05-12 广州希倍医疗科技有限公司 Preparation method of modified collagen scaffold, product and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552452A (en) * 1993-03-15 1996-09-03 Arch Development Corp. Organic tissue glue for closure of wounds
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
WO2006029571A1 (en) * 2004-09-14 2006-03-23 The University Of Hong Kong Photochemically crosslinked collagen scaffolds and methods for their preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
CA2536041A1 (en) * 2003-11-10 2005-05-26 Angiotech International Ag Medical implants and fibrosis-inducing agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552452A (en) * 1993-03-15 1996-09-03 Arch Development Corp. Organic tissue glue for closure of wounds
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
WO2006029571A1 (en) * 2004-09-14 2006-03-23 The University Of Hong Kong Photochemically crosslinked collagen scaffolds and methods for their preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008013962A2 *

Also Published As

Publication number Publication date
WO2008013962A2 (en) 2008-01-31
WO2008013962A9 (en) 2008-03-27
EP2068622A2 (en) 2009-06-17
WO2008013962A3 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
EP2068622A4 (en) Method and mixture for in-vivo photochemical cross-linking of collagen
GB2449648B (en) Apparatus and method of body characterisation
EP1981434A4 (en) Apparatus and methods for deployment of custom-length prostheses
EP1998716A4 (en) Apparatus and methods for deployment of linked prosthetic segments
EP2009509A4 (en) Method of development and development apparatus
EP2210002A4 (en) Fastening apparatus and method of making
EP1981406A4 (en) Apparatus and method for tissue closure
EP2032131A4 (en) Method of treatment
EP2299931A4 (en) Sealing apparatus and methods of use
EP2021094A4 (en) Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
EP2044026A4 (en) Method of treatment of glioma brain tumour
IL193460A0 (en) Compounds and methods for treatment of stroke
EP2169081A4 (en) Reduction treatment apparatus and method of reduction treatment
EP2117449A4 (en) Apparatus for repositioning portions of fractured bone and method of using same
IL206151A0 (en) Multiple coagulation test cartridge and method of using same
GB0803725D0 (en) Surgical apparatus and procedure
EP2142037A4 (en) Illuminated flashing toothbrush and method of use
GB0823093D0 (en) Apparatus and method for characterisation of materials
GB0620436D0 (en) Apparatus and method for stimulation of cartilage
EP1988191A4 (en) Plating apparatus and method of plating
GB0610746D0 (en) Method of treatment
EP2007303A4 (en) System and method for microablation of tissue
GB2449226B (en) Method and apparatus for analysing the structure of bone tissue
GB0603288D0 (en) Apparatus and method of using same
GB0822048D0 (en) Methods and apparatus for applying patterns of non-contiguous features

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

17P Request for examination filed

Effective date: 20090618

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120912

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/39 20060101ALI20120906BHEP

Ipc: A61L 27/24 20060101ALI20120906BHEP

Ipc: C07K 14/78 20060101ALI20120906BHEP

Ipc: A01N 25/00 20060101AFI20120906BHEP

Ipc: A61K 31/409 20060101ALI20120906BHEP

17Q First examination report despatched

Effective date: 20130614

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOLITEC PHARMA IP & INVESTMENT LTD.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180201